**Education and Professional Experience:**
1992.9 – 1997.6: Bachelor's Degree in Clinical Medicine, Zhongshan Medical University
2009.9 – 2012.6: Master's Degree in Oncology, Sun Yat-sen University
1997.7 – 2002.6: Resident Physician, The First Affiliated Hospital, Sun Yat-sen University
2002.6 – 2015.12: Attending Physician, The First Affiliated Hospital, Sun Yat-sen University
2016.1 – Present: Associate Chief Physician, The First Affiliated Hospital, Sun Yat-sen University
**Professional Affiliations:**
Youth Committee Member, Cancer Rehabilitation and Palliative Care Committee, Guangdong Anti-Cancer Association
Committee Member, Tumor Prevention and Treatment Committee, Guangdong Health Management Association
Committee Member, Gastric Cancer Committee, Guangzhou Anti-Cancer Association
**Publications:**
**A: First Author/Co-first Author/Corresponding Author**
1) Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: A meta-analysis. Gene, 2013, Oct 10;528(2):335-42. (IF= 2.138) First Author/Corresponding Author
2) XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis. Tumour Biol, 2014 Jan;35(1):447-53. (IF= 3.611) First Author/Corresponding Author
3) Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis. Tumour Biol, 2014 Apr;35(4):3905-15. (IF= 3.611)
4) A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Oncotarget, 2015 Apr 20;6(11):8676-86. (IF= 6.359)
5) Osterix transcriptional factor is involved in the metastasis of human breast cancers. Oncol Lett, 2015 Sep;10(3): 1870-1874. (IF= 1.554)
6) Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: A meta-analysis. J BUON, 2014 Dec;19(4): 917-24. (IF= 0.741) Corresponding Author
7) Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study. Mol Clin Oncol, 2014 Nov;2(6):1047-1054.
8) The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic Nasopharyngeal Carcinoma. PLoS One, 2014 Nov 13;9(11):e112581. (IF= 3.234)
9) Prediction of occult cervical lymph node metastasis in clinically negative supraglottic squamous cell carcinoma. Head Neck Oncol, 2012, Oct 27;4(3):69.
10) PSCA s2294008 C>T and rs2976392 G>A polymorphisms contribute to cancer susceptibility: evidence from published studies. Genes Cancer, 2015 May;6(5-6):254-64.
11) Experimental study on synergistic treatment of hepatocellular carcinoma with β-glucosylceramide and HBsAg-DC vaccine [J/CD]. Chinese Archives of General Surgery (Electronic Edition), 2013, 7(4):298-302.
12) Clinical study of octreotide in preventing irinotecan-induced delayed diarrhea. New Medicine, 2012, 43(3):155-158.
**B: Other Ranked Publications**
13) Zhou H, Wei J, Dai Q, Wang L, Luo J, Cheang T, Wang S. CaCO3/CaIP6 composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth. Int J Nanomedicine, 2015 Jul 1;10:4255-66. (IF= 4.383)
14) Qu MH, Zeng RF, Fang S, Dai QS, Li HP, Long JT. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Int J Pharm, 2014 Oct 20;474(1-2):112-22. (IF= 3.65)
15) Chen C, Sun P, Rong J, Weng HW, Dai QS, Ye S. Short Course Radiation in the Treatment of Localized Rectal Cancer: A Systematic Review and Meta-Analysis. Sci Rep. 2015 Jun 9;5:10953. (IF= 5.578)
16) Long J, Zhou B, Li H, Dai Q, Zhang B, Xing S, Zeng Z, Chen W, Yang J. Improvement of HbsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramide. Immunol Invest. 2013 Jan 16;42(2):137-55. (IF= 1.991)
17) Long JT, Cheang TY, Zhuo SY, Zeng RF, Dai QS, Li HP, Fang S. Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis. J Nanobiotechnology. 2014 Sep 30;12(1):37. (IF= 4.115)
18) Wang TB, Dai QS, Wei XQ, Lin WH, Shi HP, Dong WG. CXCR4 RNA interference sequence screening and its effect on the growth of colon cancer SW480 cells [J/CD]. Chinese Archives of General Surgery (Electronic Edition), 2012, 6(5):394-399.
**Monograph:** Associate Editor-in-Chief, *Practical Diagnosis and Treatment of Gastrointestinal Malignancies*, Guangdong Science and Technology Press.
العربية
